Prospects for the development of Ukraine’s pharmaceutical market in the wartime and post-war economy

The pharmaceutical market of Ukraine has undergone significant changes and challenges due to the ongoing war and associated economic difficulties. Military actions have resulted in substantial damage and destruction of production and logistics facilities, disruptions in the supply of medicines, reduced availability of pharmaceuticals for the population, and challenges in importing raw materials and finished drugs. On the other hand, this crisis situation has revealed new opportunities for the development of domestic production and localization of pharmaceutical products. This could strengthen the pharmaceutical sector, reduce dependence on imported drugs, and ensure long-term resilience of the industry during the reconstruction period. The aim of this study is to assess the current state of the pharmaceutical market in Ukraine, analyze the impact of the war on key aspects of the industry—production, logistics, import, and export of products—and explore opportunities for the sector’s adaptation and development in the post-war economy. Particular attention is paid to analyzing consumer demand, the availability of medicines, as well as the prospects for production localization, the development of generic drugs, strengthening national infrastructure, and improving the competitiveness of domestic products. The review indicates the necessity of strategic state support to create favorable conditions for the development of the pharmaceutical sector. This includes tax incentives for companies specializing in drug production, investment subsidies for the modernization and construction of new pharmaceutical plants, promotion of pharmaceutical clusters, and stimulation of scientific research and development. Key measures also involve supporting small and medium-sized pharmaceutical enterprises through financial and educational programs, creating microfinance opportunities for new manufacturing ventures, and developing training and certification programs to enhance the professional level of industry workers.

Authors

Publication Details

Journal
Scientific notes
Published
2024-12-21
DOI
https://doi.org/10.33111/vz_kneu.37.24.04.05.033.039
Primary Topic
Economic Issues in Ukraine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospects for the development of Ukraine’s pharmaceutical market in the wartime and post-war economy

Areg Movsesyan
Scientific notes
Economic Issues in Ukraine
article

Prospects for the development of Ukraine’s pharmaceutical market in the wartime and post-war economy

Areg Movsesyan
article en

Abstract

The pharmaceutical market of Ukraine has undergone significant changes and challenges due to the ongoing war and associated economic difficulties. Military actions have resulted in substantial damage and destruction of production and logistics facilities, disruptions in the supply of medicines, reduced availability of pharmaceuticals for the population, and challenges in importing raw materials and finished drugs. On the other hand, this crisis situation has revealed new opportunities for the development of domestic production and localization of pharmaceutical products. This could strengthen the pharmaceutical sector, reduce dependence on imported drugs, and ensure long-term resilience of the industry during the reconstruction period. The aim of this study is to assess the current state of the pharmaceutical market in Ukraine, analyze the impact of the war on key aspects of the industry—production, logistics, import, and export of products—and explore opportunities for the sector’s adaptation and development in the post-war economy. Particular attention is paid to analyzing consumer demand, the availability of medicines, as well as the prospects for production localization, the development of generic drugs, strengthening national infrastructure, and improving the competitiveness of domestic products. The review indicates the necessity of strategic state support to create favorable conditions for the development of the pharmaceutical sector. This includes tax incentives for companies specializing in drug production, investment subsidies for the modernization and construction of new pharmaceutical plants, promotion of pharmaceutical clusters, and stimulation of scientific research and development. Key measures also involve supporting small and medium-sized pharmaceutical enterprises through financial and educational programs, creating microfinance opportunities for new manufacturing ventures, and developing training and certification programs to enhance the professional level of industry workers.

Scientific notes(37)
Decent work and economic growth
Openalex Percentile: Top 56%
Economic Issues in Ukraine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.